FDA panel recommends Pfizer vaccine for kids 5-11; maker of COVAXIN looks to start US trials of vaccine: COVID-19 updates
Lindsay Schnell and John Bacon, USA TODAYComments Off on FDA panel recommends Pfizer vaccine for kids 5-11; maker of COVAXIN looks to start US trials of vaccine: COVID-19 updates
Children are one step closer to being able to receive a COVID-19 vaccine. Ocugen plans to begin US trials of COVAXIN in US. Latest updates.